A unique career development opportunity is coming up at the end of the month, a Preparing
Future Faculty conference. Sign up while space remains! Also, there are still postdoc
seats left in Fall 2018 communicating science courses, but not for long.
To Register: Email the Postdoc Office at email@example.com with your preferred course and
section. Placement is first come, first served. All registrants are expected to attend
and participate in every session. Postdocs may only sign up for one course a semester
2.Preparing Future Faculty Conference at SBU Jun 27-29
Postdocs interested in academic faculty jobs should consider registering for the upcoming Preparing Future Facultyconference here at Stony Brook. Sponsored by Stony Brook's Diversity Plan Faculty
Working Group, the conference will provide insights on: thefaculty job searchandhow to set up a lab.
Attendance is being capped with only a limited number of seats still available. Enroll
WHEN: June 27-29, 2018
WHERE: Hilton Garden Inn at Stony Brook University
Preparing a compelling CV Writing Research and Teaching Statements Preparing for Interviews Negotiating Job Offers Starting a Research Lab Recruiting and Mentoring Students Writing Research Proposals Networking with Professional Societies
1.NIGMS Postdoctoral Research Associate Training (PRAT)
The NIGMS PRAT Program is a competitive three-year postdoctoral fellowship program that provides high quality
research training in the basic biomedical sciences in NIH intramural research laboratories,
and prepares trainees for leadership positions in biomedical careers. The program
places special emphasis on training fellows in all scientific areas supported by NIGMS,
including but not limited to, biological chemistry, biophysics, bioinformatics, cellular
and molecular biology, computational biosciences, developmental biology, genetics,
immunology, neuroscience, pharmacology, physiology, and technology development. Appointments
are made at competitive stipend levels, commensurate with experience and recognition
of selection for this program, and fellows receive a travel and training allowance.
The PRAT Program is especially interested in ensuring the applicant pool reflects
the diversity of the biomedical Ph.D. talent pool.
Learn more at upcoming webinar:The webinar will be on Wednesday, June 20 at 1:30 PM Eastern. To access the webinar, visit the WebEx meeting page and enter the meeting number (access
code) 625 876 209 and the password MjRSPSrH. You can also attend by phone by calling
650-479-3208. Slides will be posted on the PRAT website following the event. Slides
will be posted on the NIGMS PRAT Program website following the webinar. More information
can be found here: https://loop.nigms.nih.gov/2018/05/webinar-for-postdoctoral-research-associate-training-prat-program-applicants/
2.Associate Program Officer, Natl Academies Board on Health Sciences Policy
The Forum on Drug Discovery, Development, and Translation at the National Academies
is seeking an Associate Program Officer to join their team. This position is best
suited for early career candidates with an interest in medical product R&D policy.
Excellent (written and verbal) communication skills required. Experience in science
and regulatory policy preferred.
3.Moffitt Cancer Center Innovation Fellowship, Deadline: July 1
The Office of Innovation and Industry Alliances at Moffitt Cancer Center is now accepting
applications for a unique Postdoctoral Fellowship in Innovation. This two-year program
is designed to train STEM PhD graduates with minimal knowledge of academic technology
transfer what they need to know to be hired into any technology transfer office (TTO)
or related position in the US. This program offers a very competitive compensation
package, mentorship by an experienced biotech entrepreneur, and many professional
DEADLINE: The deadline for the postdoc awards is August 1 each year, but for the other awards,
the deadlines vary. See the website for details.
5.Alzheimer Drug Discovery Foundation, NYC, Multiple Positions
The Alzheimer's Drug Discovery Foundation is a New York-based nonprofit organization on a mission to accelerate the discovery
of drugs to prevent, treat, and cure Alzheimer's disease. We strive to support the
most diverse and promising research projects around the world.
Many of our staff members have a direct connection to Alzheimer's disease and other
dementias. These personal connections drive us forward and unite us to work together
to achieve our shared mission.
ADDF seeks a Scientific Program Officerwho will report directly to the Director, Scientific Affairs and will be overseen
by ADDF's Founding Executive Director and Chief Science Officer. Seek a motivated early-career scientist seeking to accelerate the translation of research
into therapies for patients with Alzheimer's disease and related dementias. As part
of a venture philanthropy that funds academic and biotechnology programs, this role
will be integral in supporting the management of ADDF's research portfolio and strategic
partnerships with industry, investors, and other funding agencies. The Scientific
Program Officer will proactively support applicants and ADDF-funded researchers by
connecting them with resources to develop and support their programs from concept
This position requires a PhD or equivalent degree in a relevant biomedical discipline.
The ideal candidate will have: Research experience in neuroscience, neurology, or
a related field. General knowledge of drug discovery and development for CNS diseases
desired. Translational or clinical research experience is a plus. Strong project and
time management skills with the ability to manage competing requests. Excellent oral
communications and writing skills with demonstrated ability to communicate to both
scientific and lay audiences. Strong interpersonal skills and the ability to work
closely with key opinion leaders, partner organizations, donors, and staff. https://www.alzdiscovery.org/about-addf/join-our-team/scientific-program-officer
ADDF seeks a Program Officer or Assistant Director, Aging & Alzheimer’s Prevention Program who will report directly to the Director of Aging & Alzheimer’s Prevention and will
be overseen by ADDF’s Founding Executive Director and Chief Science Officer. Dementia
prevention has been a major topic of research for decades but the vast majority of
research designs cannot conclusively prove or disprove a given therapeutic approach.
Similarly, therapeutic strategies to slow aging are extremely difficult to prove yet
could be the most effective approaches to extend healthy active life and delay the
onset of dementia. https://www.alzdiscovery.org/about-addf/join-our-team/officer-director-aging-alzheimers-prevention-program
ADDF seeks a Biomarkers Scientific Program Officer, Scientific Affairs Program who will be a motivated early-career scientist seeking to accelerate the translation
of research into therapies for patients with Alzheimer's disease and related dementias.
An important component of this mission is to develop biomarkers that can (1) accurately
diagnose (2) properly stratify and enrich patient populations (3) demonstrate target
engagement for novel therapies and (4) reliably monitor disease progression and response
to treatment. As part of a venture philanthropy that funds academic and biotechnology
programs, this position will help maintain the biomarkers research program. This includes
management of a research portfolio, development of strategic partnerships, and support
of applicants through connecting them with resources to progress their programs towards
ADDF seeks a Consultant (Part-time), for the Aging & Alzheimer’s Prevention Program. The Alzheimer’s Drug Discovery Foundation (ADDF) works towards to advance potential
therapies and prevent Alzheimer’s disease and related dementias. We are partnering
with a third party to develop a platform that aggregates data from patients to build
predictive models of Alzheimer’s risk and potential response to drugs. Alzheimer’s
disease develops over the course of decades, and many of the choices we make in mid-life
affect our future risk of the disease. A growing number of biomarker and genetic studies
are improving our ability to determine one’s risk of developing dementia. Additionally,
Alzheimer’s disease is heterogenous, and certain patients may respond differently
to certain medications or treatments. Therefore, there is a great need for longitudinal
deep phenotyping of patients in the clinic.
1.Have you completed the Postdoc and Research Scientist Info Form??
The Postdoc and Research Scientist Info Form helps the Office of Postdoctoral Affairs track our postdoctoral population, which
in turn helps us with our reporting requirements and serving our postdocs better.
If you haven't completed it, could you take a few minutes and help us out?